Similar companies
Income Statement (NONE)
| Q2 '24 | QoQ | |
|---|---|---|
| Operating expense | 1.3M | 0% |
| Net Income | -960,000 | 0% |
| EBITDA | -960,000 | 24.5% |
Balance Sheet (NONE)
| Q2 '24 | QoQ | |
|---|---|---|
| Total Assets | 21M | 0% |
| Total Liabilities | 1.2M | 78.3% |
| Total Equity | 16M | 0% |
| Shares Outstanding | 3.7M | 0% |
Cash Flow (NONE)
| Q2 '24 | QoQ | |
|---|---|---|
| Cash from operations | -140,000 | 0% |
| Cash from financing | -18M | 0% |
Financial Highlights for NewGenIvf Group in Q2 '24
Operating Expenses for this period were 1.3M, showing a 0% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -960,000, showing a 0% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -960,000, showing a 24.5% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
The company's performance remained stable this quarter with no significant positive or negative changes in the key financial metrics.
